Epidemiology of neural tube defects

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 4, Issue 4, 1998, Pages 241-246

  Olney, Richard ^a,b   Mulinare, Joseph ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anencephaly; Epidemiology; Meningomyelocele; Neural tube defects; Population Surveillance; Risk factors

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; BIRTH CERTIFICATE; ETHNIC DIFFERENCE; GEOGRAPHIC PATHOLOGY; HUMAN; MASS SCREENING; MATERNAL NUTRITION; MEDICAL RECORD; MENINGOMYELOCELE; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS;

EID: 0032423173     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1998)4:4<241::AID-MRDD2>3.0.CO;2-Y     Document Type: Review

References (32)

1. Bower C, Raymond M, Lumley J, et al. Trends in neural tube defects 1980-1989. Med J Aust 1993;158:152-154.
2. Centers for Disease Control and Prevention. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR 1995a;44(55-4): 1-13.
3. Centers for Disease Control and Prevention. Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR 1995b; 44:694-699.
4. Centers for Disease Control and Prevention. Prevalence of spina bifida at birth-United States, 1983-1990: A comparison of two surveillance systems. MMWR 1996;45:15-26.
5. Cotton P. Finding neural tube "zippers" may let geneticists tailor prevention of defects [news]. JAMA 1993;270:1663-1664.
6. Cowchock S. Neural tube defects [letter]. J Med Genet 1982;19:393.
7. ElwoodJM, Little J, ElwoodJH. Epidemiology and Control of Neural Tube Defects. New York: Oxford University Press, 1992:1-903.
8. Erickson JD. Introduction: Birth defects surveillance in the United States. Teratology 1997;56: 1-4.
9. EUROCAT Working Group. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. J Epidemiol Community Health 1991;45: 52-58.
10. Fraser FC, Maldoff SR, Lippman-Hand A. Evidence against a female specific class of neural tube defect [letter]. J Med Genet 1983:20:78-79.
11. Gordis L. The scope of screening. J Med Screen 1994:1:98-100.
12. Haddix AC, Teutsch SM, Shaffer PA, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press, 1996:1-219.
13. Hall JG, Friedman JM, Kenna DA, et al. Clinical, genetic, and epidemiological factors in neural tube defects. Ain J Hum Genet 1988:43:827837.
14. Hunter AGW. Brain and spinal cord. In: Stevenson RE, Hall JG, Goodman RM, eds. Human Malformations and Related Anomalies. Volume 2. New York: Oxford University Press, 1993:109-138.
15. International Clearinghouse for Birth Defects Monitoring Systems. Congenital Malformations Worldwide: A Report from the International Clearinghouse for Birth Defects Monitoring Systems. Amsterdam: Elsevier Science Publishers, 1991:41-57.
16. International Clearinghouse for Birth Defects Monitoring Systems. International Clearinghouse for Birth Defects Monitoring Systems Annual Report 1996. Rome: International Centre for Birth Defects, 1996:18-128.
17. James LM. Maps of birth defects occurrence in the U.S., Birth Defects Monitoring Program (BDMP)/CPHA, 1970-1987. Teratology 1993:48:551-646.
18. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects: Clues from epidemiology. AmJ Epidemiol 1982;! 15: 538-548.
19. Kuppermann M, Gates E, Washington AE. Racialethnic differences in prenatal diagnostic test use and outcomes: Preferences, socioeconom-ics, or patient knowledge? Obstet Gynecol 1996:87:675-682.
20. Leek I. Epidemiological clues to the causation of neural tube defects. In: Dobbing J, ed. Prevention of Spina Bifida and Other Neural Tube Defects. London: Academic Press, 1983:155-182.
21. Lynberg MC, Edmonds LD (1992): Surveillance of birth defects. In: Halperin W, Baker EL, Monson RR, eds. Public Health Surveillance. New York: Van Nostrand Reinhold, 1992: 15 VI77.
22. Moore CA, Li S, Li Z, et al. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 1997;73: . 113-118.
23. Myrianthopoulos NC, Melnick M. Studies in neural tube defects. I. Epidemiologie and etiologic aspects. Am J Med Genet 1987;26: 783-796.
24. Roberts HE, Moore CA, Cragan JD, et al. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics 1995;96:880-883.
25. Robinson A, Linden MG. Clinical Genetics Handbook. 2nd ed. Boston: Blackwell Scientific Publications, 1993:125-130.
26. Sever LE. Epidemiologie aspects of neural tube defects. In: Crandall BF, Brazier MAB, eds. Prevention of Neural Tube Defects. London: Academic Press, 1978:75-89.
27. Sever LE, Emanuel I. Intergenerational factors in the etiology of anencephalus and spina bifida. Dev Med Child Neurol 1981:23:151-154.
28. Shapiro K. Anencephaly. In Buyse ML, ed. Birth Defects Encyclopedia. Dover, MA: Blackwell Scientific Publications, 1990:139-140.
29. Van Alien MI, Kalousek DK, ChemoffGF, et al. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 1993;47: 723-743.
30. Watkins ML. Efficacy of folic acid prophylaxis for the prevention of neural tube defects. Ment Ret Dev Dis Res Rev 1998; this volume:19.
31. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997;19:33-43.
32. Yen IH, Khoury MJ, Erickson JD, et al. The changing epidemiology of neural tube defects: United States, 1968-1989. Am J Dis Child 1992:146:857-861.